512.39 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
510.46
↘ 1.93 (0.38%)
POST MARKET (AS OF 06:05 PM EDT)
Post Market
AS OF 06:05 PM EDT
510.46
↘ 1.93 (0.38%)
Market: CLOSED
Open?$518.00
High?$522.18
Low?$500.97
Prev. Close?$512.39
Volume?205.6K
Avg. Volume?348.1K
VWAP?$515.17
Rel. Volume?0.59x
Bid / Ask
Bid?$509.08 × 40
Ask?$516.00 × 400
Spread?$6.92
Midpoint?$512.54
Valuation & Ratios
Market Cap?11.8B
Shares Out?22.9M
Float?16.4M
Float %?71.6%
P/E Ratio?N/A
P/B Ratio?19.50
EPS?-$12.57
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.00Strong
Quick Ratio?3.76Strong
Cash Ratio?0.64Adequate
Debt/Equity?0.56Moderate
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?19.50HIGH▾
P/S?12.26HIGH▾
P/FCF?N/A▾
EV/EBITDA?-39.8CHEAP▾
EV/Sales?12.41HIGH▾
Returns & Efficiency
ROE?-47.8%WEAK▾
ROA?-22.9%WEAK▾
Cash Flow & Enterprise
FCF?$-190020000
Enterprise Value?$11.9B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
11.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
200 BARR HARBOR DRIVE, SUITE 400
WEST CONSHOHOCKEN, PA 19428
Phone: 404-380-9263
WEST CONSHOHOCKEN, PA 19428
Phone: 404-380-9263